ArticleFrontiers in public health2026
The weight of pills: medication use and fall incidence in Saudi community-dwelling adults aged 50 years and older: a 10-month longitudinal study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the growing body of global evidence on the use of medications associated with a risk of falls, there is a lack of research on medications and future fall incidence in the Saudi population. Objective: This study aimed to explore the association of the baseline number of medications and polypharmacy with fall incidence at 4-6 and 9-10 months of follow-up among Saudi adults aged 50 years and older. Methods: A prospective longitudinal study was conducted among 211 Saudi adults aged 50 years and older. Participants were recruited from community settings including hospitals, clinics, malls, and mosques. Data were collected at three assessment time points: baseline (February-April 2022), 4-6 months (August-September 2022), and 9-10 months (November 2022-January 2023). The number of medications and polypharmacy (≥4 medications) were verified during participant interviews at baseline. Fall events (fall vs. no fall) were documented at three time points across 10 months of follow-up, including baseline fall history, fall incidence at 4-6 months, and fall incidence at 9-10 months of follow-up. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: Baseline polypharmacy was significantly associated with an approximately fourfold increase in fall incidence (HR: 3.99, 95% CI: 1.63-9.81; Conclusion: This exploratory study suggests a possible association between baseline polypharmacy and fall incidence over a follow-up period of up to 10 months among community-dwelling Saudi adults aged 50 years and older. However, these findings were based on a small polypharmacy subgroup (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.